1-2 of 2
Debra Resta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Nilotinib, a Novel Inhibitor of c-Kit, PDGFR, and Bcr-Abl, Administered to Patients with Systemic Mastocytosis.

Andreas Hochhaus, MD, Oliver G. Ottmann, MD, STephanie Lauber, MD, Timothy Hughes, MD, Gregor Verhoef, MD, Anthony P. Schwarer, MD, Alois Gratwohl, MD, Teresa Rafferty, RN, Debra Resta, RN, Norbert Gattermann, MD
Journal: Blood
Blood (2006) 108 (11): 2703.
https://doi.org/10.1182/blood.V108.11.2703.2703
Published: 2006
Journal Articles

Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase

Clinical Trials & Observations
Hagop M. Kantarjian, Jorge Cortes, Susan O'Brien, Francis J. Giles, Maher Albitar, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Deborah A. Thomas, Debra Resta, Moshe Talpaz
Journal: Blood
Blood (2002) 99 (10): 3547–3553.
https://doi.org/10.1182/blood.V99.10.3547
Published: 2002